Description
Biochemical Overview & In-Vitro Research Applications
ACE-031 Research Peptide is an analytical-grade laboratory reagent characterized in peer-reviewed preclinical literature for mechanistic studies involving Activin Receptor Type IIB Signalling & Myostatin Binding. Supplied by Peptide Verge (United Kingdom) exclusively to university departments, biotechnology facilities, and qualified independent researchers conducting non-clinical in-vitro receptor binding, cell-signalling, and chromatographic calibration assays.
Analytical & Molecular Specifications
| Compound Designation | ACE-031 Research Peptide |
|---|---|
| CAS Registry Number | 1198174-61-6 |
| Molecular Formula | Recombinant ActRIIB-IgG1 Fusion |
| Molecular Weight | ~83.6 kDa (Dimer) |
| Target Purity Specification | ≥98.5% – 99.0% (RP-HPLC-UV Specification) |
| Physical Presentation | Lyophilized Solid Powder (Sterile Crimp Vial) |
| UK Laboratory Storage | -20 °C Desiccated; Store Reconstituted Aliquots at 2–8 °C |
Laboratory Documentation & Batch Verification
Reference chemical specifications (CAS, molecular weight, and RP-HPLC target grade) are documented above. Batch-specific analytical release certificates are assigned upon active UK lot intake; view published batch records in our UK Certificates of Analysis Registry or contact UK Laboratory Support with your lot code.
Compound Frequently Asked Questions
What primary pathway is ACE-031 Research Peptide used to investigate in vitro?
In controlled laboratory literature, ACE-031 Research Peptide is utilized as a selective biochemical probe for studying Activin Receptor Type IIB Signalling & Myostatin Binding in cell-free and cultured cellular assays.
How should lyophilized ACE-031 Research Peptide vials be stored upon UK delivery?
Store unopened vials at -20 °C Desiccated; Store Reconstituted Aliquots at 2–8 °C. Allow vials to equilibrate to ambient laboratory temperature inside a desiccator prior to sterile solvent reconstitution to avoid condensation.
Is ACE-031 Research Peptide licensed for human, clinical, or cosmetic use in the UK?
No. Under the UK Human Medicines Regulations 2012 (SI 2012/1916), this compound is supplied strictly as an analytical laboratory reagent for qualified in-vitro research only and is never intended for human or veterinary administration.
PV-UK-ACE031), contact support@peptideverge.com.
Reviews
There are no reviews yet.